Taro Drug Patent Portfolio
Taro owns 1 orange book drug protected by 2 US patents Given below is the list of Taro's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7560445 | Process for preparing malathion for pharmaceutical use | 01 Feb, 2027 | Active |
| US7977324 | Process for preparing malathion for pharmaceutical use | 14 Aug, 2026 | Active |
Latest Legal Activities on Taro's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Taro.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 12 Jan, 2023 | US7977324 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Jan, 2021 | US7560445 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Nov, 2018 | US7977324 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 09 Mar, 2017 | US7977324 |
|
Email Notification
Critical
| 09 Mar, 2017 | US7977324 |
|
Correspondence Address Change
Critical
| 07 Mar, 2017 | US7977324 |
|
Email Notification
Critical
| 23 Feb, 2017 | US7560445 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 23 Feb, 2017 | US7560445 (Litigated) |
|
Correspondence Address Change
Critical
| 21 Feb, 2017 | US7560445 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 04 Sep, 2012 | US7977324 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Jul, 2011 | US7977324 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Jul, 2011 | US7977324 |
|
Email Notification
Critical
| 23 Jun, 2011 | US7977324 |
|
Issue Notification Mailed
Critical
| 22 Jun, 2011 | US7977324 |
| Dispatch to FDC | 16 Jun, 2011 | US7977324 |
Taro's Family Patents
Recent FDA approvals and tentative approvals for Taro
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Azelaic Acid |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 19 Apr, 2021 |
Taro Drug List
Given below is the complete list of Taro's drugs and the patents protecting them.
1. Ovide
Ovide is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7560445 | Process for preparing malathion for pharmaceutical use |
01 Feb, 2027
(1 year, 26 days from now)
| Active |
| US7977324 | Process for preparing malathion for pharmaceutical use |
14 Aug, 2026
(7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ovide's drug page